As of 2024-12-13, the Relative Valuation of Merck & Co Inc (MRK) is 81.87 USD. This relative valuation is based on P/E multiples. With the latest stock price at 101.25 USD, the upside of Merck & Co Inc based on Relative Valuation is -19.1%.
The range of the Relative Valuation is 24.62 - 150.21 USD.
| Range | Selected | |
| Trailing P/E multiples | 25.1x - 31.3x | 28.0x |
| Forward P/E multiples | 27.8x - 41.6x | 33.3x |
| Fair Price | 24.62 - 150.21 | 81.87 |
| Upside | -75.7% - 48.4% | -19.1% |
| Date | P/E |
| 2024-12-12 | 21.08 |
| 2024-12-11 | 20.77 |
| 2024-12-10 | 21.03 |
| 2024-12-09 | 21.61 |
| 2024-12-06 | 21.47 |
| 2024-12-05 | 21.56 |
| 2024-12-04 | 21.11 |
| 2024-12-03 | 21.21 |
| 2024-12-02 | 20.95 |
| 2024-11-29 | 21.17 |
| 2024-11-27 | 21.47 |
| 2024-11-26 | 21.16 |
| 2024-11-25 | 21.07 |
| 2024-11-22 | 20.65 |
| 2024-11-21 | 20.79 |
| 2024-11-20 | 20.29 |
| 2024-11-19 | 20.10 |
| 2024-11-18 | 20.11 |
| 2024-11-15 | 20.06 |
| 2024-11-14 | 20.48 |
| 2024-11-13 | 20.51 |
| 2024-11-12 | 20.53 |
| 2024-11-11 | 20.98 |
| 2024-11-08 | 21.43 |
| 2024-11-07 | 21.07 |
| 2024-11-06 | 20.98 |
| 2024-11-05 | 21.17 |
| 2024-11-04 | 21.21 |
| 2024-11-01 | 21.21 |
| 2024-10-31 | 21.31 |
| 2024-10-30 | 21.83 |
| 2024-10-29 | 21.60 |
| 2024-10-28 | 21.70 |
| 2024-10-25 | 21.65 |
| 2024-10-24 | 22.05 |
| 2024-10-23 | 22.15 |
| 2024-10-22 | 22.21 |
| 2024-10-21 | 22.14 |
| 2024-10-18 | 22.64 |
| 2024-10-17 | 22.85 |
| 2024-10-16 | 22.99 |
| 2024-10-15 | 23.22 |
| 2024-10-14 | 22.84 |
| 2024-10-11 | 22.85 |
| 2024-10-10 | 22.78 |
| 2024-10-09 | 22.96 |
| 2024-10-08 | 22.60 |
| 2024-10-07 | 22.61 |
| 2024-10-04 | 22.86 |
| 2024-10-03 | 22.94 |